During drug quality audits in Japan, facility layout and operational flows are reviewed by examining compliance with Good Manufacturing Practices (GMP). Auditors assess spatial organization, equipment placement, and workflow efficiency to ensure contamination prevention, safety, and regulatory adherence, focusing on optimizing production processes and maintaining high-quality standards throughout the facility.
